The Graves' orbitopathy market is undergoing rapid change, driven by advancements in targeted treatments. TEPEZZA ...
Myc dysregulation in activated macrophages impairs antioxidant defenses, locking them in a vicious cycle that amplifies type I interferon signaling, driving hyperinflammation and immunosuppression.